|
|
Article: New findings from Y.P. Liu and co-authors in the area of life sciences published.
- Article from:
- Blood Weekly
- Article date:
- November 12, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
"The study examined the effects of a norepinephrine transporter ( NET) inhibitor reboxetine (RBX) on an attentional performance test. Adult SD rats trained with five-choice serial reaction time task (5-CSRTT) were administered with RBX ( 0, 3.0 and 10 mg/kg) in the testing day," researchers in Taipei, Taiwan report (see also Life Sciences).
"Alpha-1 adrenergic receptor antagonist PRA and alpha-2 adrenergic receptor antagonist RX821002 were used to clarify the RBX effect. revealed that rat received RBX at 10 mg/kg had an increase in the percentage of the correct response and decreases in the numbers of premature response. Alpha-1 adrenergic receptor antagonist ...
Related newspaper, magazine, and journal articles:
|
|
Article: Investigators at Kyung-Hee University, Biomedical ...
Blood Weekly;
January 1, 2009 ;
700+ words
... ... Kyung-Hee University, Biomedical Science Institute (see also Life Sciences). The researchers concluded ... contact J.J. Lee, Biomedical Science Institute, Dept. of ... South Korea, Seoul, Life Sciences, Biomedicine, Bioengineering ...
|
|